CytoSorbents Corporation (CTSO)

[ranchhand71]

Banker friend attending the Geneva Presentation suggests that in 12 months Fresenius will have ramped significantly and the U.S trials will have treated 200 patients or more yielding insights and offl label anecdotal feedback for several other uses could result in an acquisition offer. Speculation on what Board would then accept. Company will be profitable excluding U:S. Trial costs. Some cancer work may have progressed by then.
$25-35??